Abstract 2114: Exploring derivatives of FDA-Approved Drug, Candesartan, as Potential Inhibitors of PRL3

Autor: Bennett, Grace, Starczewski, Julia, Whalen, Tristan, Weafer, Kate, dela Cerna, Mark Vincent
Zdroj: In Journal of Biological Chemistry 2023 299(3) Supplement
Databáze: ScienceDirect